O

Option Care Health

Largest independent home infusion therapy provider

Infusion RN

Full-Time
$36.89 - $61.49
Junior
Bachelor's
Ocala, FL, USA
In PersonTravel up to 100% of the time for business purposes.
Medical, Clinical & VeterinaryNursing & Frontline Patient Care

About the job

Requirements
  • Hold an active and unrestricted registered nurse license in the state of practice.
  • Have at least 1 year of nursing experience.
  • Hold current CPR certification.
  • Demonstrate competency in patient care standards, safe service delivery, and infusion skill sets applicable to agency programs and service needs; obtain advanced certification and training as applicable.
  • Hold the required license to operate a motor vehicle in the state of practice, have access to a vehicle for business travel, and provide proof of liability insurance.
  • Have basic knowledge of computer operating systems and software applications, and the ability to apply nursing technology tools to communicate and document care.
  • Be able to meet the stated physical demands, including lifting up to 50 pounds and a maximum of 75 pounds, and have the required fine motor skills and visual acuity.
  • Use required personal protective equipment and a functioning communication device in routine and emergency situations.
  • Be willing to travel up to 100% of the time for business purposes.
Responsibilities
  • Initiate, develop, and implement intermediate nursing plan-of-care treatments; evaluate patient progress; organize and provide direct patient care, treatments, medication administration, and patient and caregiver education; and modify treatment plans in response to patient status or physician orders.
  • Assess patients’ needs and physical status at each skilled visit using health data and interviews; reassess needs and response to therapy; obtain and clarify physician orders; promptly inform physicians of significant changes; and provide written summaries with supplemental orders.
  • Train and mentor Infusion Nurse I staff as needed to support patient safety and compliance.
  • Teach patients and families using a patient-centered approach to help them independently manage prescribed therapy and care in line with treatment goals.
  • Communicate with the clinical team, medical providers, patients, and caregivers to support continuity of care; complete visit documentation in real time and submit it within established timelines; and follow documentation, abbreviation, and correction policies.
  • Coordinate discharge planning, prepare discharge summaries and patient instructions, and report care needs, progress, and goals when transferring care.
  • Comply with agency operations, company policies and procedures, professional standards, applicable regulations and guidelines, and accreditation standards.
  • Use computers and automation technologies to validate treatment orders, communicate care provided, and follow the assigned visit schedule.
  • Respond promptly and appropriately to patient requests and initiate emergency procedures when necessary.
  • Maintain ethical and professional conduct and follow established programs and practices consistent with policies and procedures.
  • Safeguard confidential patient and company information in accordance with legal and ethical guidelines, including HIPAA.
  • Explain the company’s scope of services and instruct patients about related financial obligations and service charges.
  • Complete required training, in-services, and continuing education to maintain competency and professional licensure and demonstrate knowledge of care management in home and alternate care settings.
  • Provide oversight and coordination of paraprofessionals in the home and, when applicable, act as supervisor in the absence of the supervisor or nurse manager in accordance with regulations.
  • Participate in multidisciplinary team conferences and provide precepting, training, mentoring, orientation, onboarding, and supervisory activities for other nurses as assigned.
  • Participate in nursing department on-call responsibilities.
  • Perform other related duties as directed by the supervisor.
  • When applicable, insert PICC lines and midlines pursuant to physician orders.
  • When applicable, troubleshoot and declot obstructed central-line catheters.
  • When applicable, monitor PICC lines and midlines and educate patients on line-infection prevention and routine care.
Desired Qualifications
  • A Bachelor of Science in Nursing from an accredited school of nursing is preferred.
  • One to two years of previous infusion nursing experience is preferred.

About the company

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Bannockburn, Illinois

Founded

1979

Get referred to Option Care Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 29, 2026 Q2 revenue reached $1.44 billion, while acute therapy and IG Neuro strengthened.
  • Management stabilized CID patient census in Q2 2026 and kept full-year revenue guidance unchanged.
  • The company repurchased $150 million in Q2 2026, signaling confidence and shareholder-return capacity.

What critics are saying

  • August 2026 guidance still bakes in a 600-basis-point CID revenue headwind and $55 million gross profit hit.
  • July 29, 2026 Q2 buyback of $150 million masks weak top-line momentum and analyst skepticism.
  • Biosimilar erosion and payer reverification pressure can permanently shrink chronic volumes if retention stays broken.

What makes Option Care Health unique

  • Option Care Health leads U.S. independent home and alternate-site infusion, with nationwide clinician density.
  • Its payer, biopharma, and prescriber relationships create switching costs across chronic and acute therapies.
  • August 27, 2026 guidance shows durable cash generation, with at least $320 million operating cash flow.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

Bonding Time Off

401(k) Retirement Plan

401(k) Company Match

Health Savings Account/Flexible Spending Account

Flexible Spending Accounts

Tuition Reimbursement

Family Support

Mental Health Support

Company Paid Life Insurance

Award/Recognition Programs

Company News

Yahoo Finance
Oct 6th, 2026
McKesson and Clayton Dubilier & Rice near $5B deal to acquire Option Care Health

Option Care Health shares jumped 33.2% in pre-market trading after the Financial Times reported McKesson and Clayton Dubilier & Rice are nearing a transaction valued at over $5 billion to acquire the alternate site health provider. According to the report, the deal would involve the two firms partnering to buy the infusion services provider, which they view as undervalued. Large-scale buyout discussions typically drive market optimism as investors anticipate acquisition premiums. The move is significant for Option Care Health, whose shares have experienced 13 movements greater than 5% over the past year. At $31.03 per share, the stock is trading 15.2% below its 52-week high but remains down 3.8% year-to-date.

Central Charts
Oct 6th, 2026
CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health

CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today that they have

Yahoo Finance
Jul 29th, 2026
Option Care Health Q2 beats expectations with $1.4B revenue, narrows full-year guidance

Option Care Health reported second-quarter 2026 results that exceeded expectations. Revenue rose 7% sequentially to $1.4 billion, whilst adjusted EBITDA increased 12% to $117.5 million and adjusted EPS reached $0.45. Operating cash flow totalled $184 million. Acute therapies posted high-single-digit organic growth, while chronic revenue improved sequentially as the CID portfolio began to stabilise. However, CID-related pressure is expected to reduce 2026 revenue by roughly 600 basis points and gross profit by $55 million. The home and alternate-site infusion provider maintained its full-year revenue guidance at $5.675 billion to $5.775 billion. Adjusted EBITDA guidance was narrowed to $480 million to $495 million, and adjusted EPS guidance to $1.85 to $1.92. The company repurchased $150 million of shares, nearly 5% of shares outstanding.

Yahoo Finance
Jul 29th, 2026
Option Care Health reports $1.44B Q2 revenue, up 1.9%, and raises $150M share buyback

Option Care Health, the largest independent provider of home and alternate site infusion services in the US, reported second quarter 2026 results. Net revenue reached $1.44 billion, up 1.9% year-over-year. The company posted net income of $53.9 million, up 6.7%, with diluted earnings per share of $0.35, up 12.9%. Adjusted EBITDA grew 3.0% to $117.5 million. The company repurchased $150 million of outstanding shares during the quarter. For full year 2026, Option Care Health expects net revenue between $5.68 billion and $5.78 billion, with adjusted diluted earnings per share of $1.85 to $1.92. The company forecasts adjusted EBITDA of $480 million to $495 million and operating cash flow of at least $320 million.

Yahoo Finance
Jun 9th, 2026
Goldman Sachs initiates Option Care Health coverage with neutral rating, $22 price target

Option Care Health shares rose 3.5% after Goldman Sachs initiated coverage with a Neutral rating and a $22 price target, suggesting potential upside from the stock's recent price of $20.51. The move comes after the stock declined 33% over the previous six months. Whilst Goldman Sachs took a cautious stance, other firms including Deutsche Bank and UBS maintain Buy ratings on the stock. The company recently reported weak first-quarter 2026 results, with revenue of $1.35 billion missing forecasts despite a 1.3% year-on-year increase. Option Care Health also lowered its full-year revenue guidance to $5.73 billion, below analyst estimates. The stock is down 35.5% year-to-date and trading 43.2% below its 52-week high.